Meredith A. Chabrier

816 total citations
7 papers, 473 citations indexed

About

Meredith A. Chabrier is a scholar working on Cellular and Molecular Neuroscience, Physiology and Pharmacology. According to data from OpenAlex, Meredith A. Chabrier has authored 7 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cellular and Molecular Neuroscience, 4 papers in Physiology and 3 papers in Pharmacology. Recurrent topics in Meredith A. Chabrier's work include Alzheimer's disease research and treatments (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Nerve injury and regeneration (2 papers). Meredith A. Chabrier is often cited by papers focused on Alzheimer's disease research and treatments (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Nerve injury and regeneration (2 papers). Meredith A. Chabrier collaborates with scholars based in United States and Germany. Meredith A. Chabrier's co-authors include Frank M. LaFerla, Mathew Blurton‐Jones, David Cheng, Kim N. Green, Noo Li Jeon, Carl W. Cotman, Christina Tu, Wayne W. Poon, Hilda Martínez‐Coria and Nicholas A. Castello and has published in prestigious journals such as Journal of Neuroscience, Neuroscience and American Journal Of Pathology.

In The Last Decade

Meredith A. Chabrier

7 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meredith A. Chabrier United States 6 298 203 149 95 82 7 473
Wipawan Thangnipon Thailand 8 203 0.7× 255 1.3× 166 1.1× 69 0.7× 64 0.8× 16 560
Ramsey Najm United States 4 315 1.1× 132 0.7× 215 1.4× 67 0.7× 149 1.8× 4 529
Mariajose Metcalfe United States 7 186 0.6× 157 0.8× 299 2.0× 56 0.6× 76 0.9× 14 526
Céline Héraud France 15 440 1.5× 243 1.2× 247 1.7× 135 1.4× 151 1.8× 24 695
Sandrine Sanchez United States 13 181 0.6× 144 0.7× 210 1.4× 55 0.6× 83 1.0× 18 470
Chloe K. Nobuhara United States 9 486 1.6× 220 1.1× 294 2.0× 75 0.8× 216 2.6× 14 696
Gilles Bru‐Mercier United Kingdom 10 194 0.7× 252 1.2× 264 1.8× 62 0.7× 59 0.7× 18 641
Masafumi Shimojo Japan 10 201 0.7× 153 0.8× 158 1.1× 42 0.4× 65 0.8× 17 393
Iftach Dolev Israel 8 484 1.6× 318 1.6× 174 1.2× 149 1.6× 105 1.3× 13 672
Cara L. Croft United States 13 344 1.2× 185 0.9× 245 1.6× 53 0.6× 178 2.2× 18 603

Countries citing papers authored by Meredith A. Chabrier

Since Specialization
Citations

This map shows the geographic impact of Meredith A. Chabrier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meredith A. Chabrier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meredith A. Chabrier more than expected).

Fields of papers citing papers by Meredith A. Chabrier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meredith A. Chabrier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meredith A. Chabrier. The network helps show where Meredith A. Chabrier may publish in the future.

Co-authorship network of co-authors of Meredith A. Chabrier

This figure shows the co-authorship network connecting the top 25 collaborators of Meredith A. Chabrier. A scholar is included among the top collaborators of Meredith A. Chabrier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meredith A. Chabrier. Meredith A. Chabrier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Chabrier, Meredith A., David Cheng, Nicholas A. Castello, Kim N. Green, & Frank M. LaFerla. (2014). Synergistic effects of amyloid-beta and wild-type human tau on dendritic spine loss in a floxed double transgenic model of Alzheimer's disease. Neurobiology of Disease. 64. 107–117. 79 indexed citations
2.
Yeung, Stephen T., et al.. (2013). Impact of hippocampal neuronal ablation on neurogenesis and cognition in the aged brain. Neuroscience. 259. 214–222. 32 indexed citations
3.
Medeiros, Rodrigo, Masashi Kitazawa, Meredith A. Chabrier, et al.. (2012). Calpain Inhibitor A-705253 Mitigates Alzheimer's Disease–Like Pathology and Cognitive Decline in Aged 3xTgAD Mice. American Journal Of Pathology. 181(2). 616–625. 70 indexed citations
4.
Chabrier, Meredith A., et al.. (2012). P3‐060: Soluble Aβ promotes wild‐type tau pathology in vivo. Alzheimer s & Dementia. 8(4S_Part_13). 1 indexed citations
5.
Chabrier, Meredith A., et al.. (2012). Soluble Aβ Promotes Wild-Type Tau PathologyIn Vivo. Journal of Neuroscience. 32(48). 17345–17350. 102 indexed citations
6.
Medeiros, Rodrigo, Meredith A. Chabrier, & Frank M. LaFerla. (2012). Elucidating the Triggers, Progression, and Effects of Alzheimer's Disease. Journal of Alzheimer s Disease. 33(s1). S195–S210. 26 indexed citations
7.
Poon, Wayne W., Mathew Blurton‐Jones, Christina Tu, et al.. (2009). β-Amyloid impairs axonal BDNF retrograde trafficking. Neurobiology of Aging. 32(5). 821–833. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026